Efficacy and Safety of Combination Therapy With Immune Checkpoint Inhibitors and Chemotherapy With Gemcitabine and Nab‐Paclitaxel in Pancreatic Cancer: A Systematic Review
Combining ICIs with gemcitabine and nab-paclitaxel appears feasible and safe, with signals of improved efficacy compared with chemotherapy alone. However, evidence remains limited, and further large-scale trials are warranted to confirm survival benefits and optimize therapeutic strategies in pancreatic cancer.
Authors
- Hanye Sohrabi (ORCID: https://orcid.org/0000-0002-4395-7991)
- Seyed Mohammad Ghavam
- Nima Rezaei
- Sina Azadnajafabad
Institutions
- Universal Scientific Education and Research Network (IR)
- Children's Medical Center (IR)
- Tehran University of Medical Sciences (IR)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1002/cam4.71637
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00